Latest news with #DevarasettySaiVikas
Time of India
2 days ago
- Time of India
PMLA court takes cognisance of ED case against Lucent Drugs for illegal Tramadol exports to Pak
1 2 3 Hyderabad: The special court for PMLA cases in Hyderabad has taken cognisance of a prosecution complaint filed by the Enforcement Directorate against Lucent Drugs Private Limited and its top executives for allegedly exporting large consignments of the psychotropic drug Tramadol to Pakistan via Denmark and Malaysia, in violation of Indian export regulations. On Aug 6, the court admitted the complaint after the ED's probe revealed that the company routed 13,800 kg of Tramadol, valued at ₹4.1 crore, to Pakistan through Denmark-based CHR Olesen Pharmaceuticals, and another 5,000 kg, worth ₹1.3 crore, through Malaysia-based SM Biomed. The agency has attached immovable properties worth ₹5.4 crore belonging to the company. Tramadol, often referred to as the 'ISIS drug' due to its widespread misuse by ISIS fighters and for treating war injuries, is a controlled psychotropic substance under the Narcotic Drugs and Psychotropic Substances Act. The ED's investigation began following a complaint from the Narcotics Control Bureau's Bengaluru zonal unit. You Can Also Check: Hyderabad AQI | Weather in Hyderabad | Bank Holidays in Hyderabad | Public Holidays in Hyderabad According to the ED, Lucent Drugs and its officials, including managing director Vinod Jain, associate vice-president Devarasetty Sai Vikas, and logistics and sales executive Gangula Eswara Rao, forged records and export authorisations to carry out the shipments. While the company initially obtained a no-objection certificate from the Central Bureau of Narcotics for export to Pakistan, the approval was later withdrawn. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Learn 57+ Languages Easily with AI [Join] Talkpal AI Sign Up Undo To circumvent the ban, the accused allegedly used intermediaries in Denmark and Malaysia to disguise the final destination. The ED contends that the illegal exports generated ₹5.4 crore in proceeds of crime, which were channelled into Lucent Drugs' regular business accounts and projected as legitimate sales from other countries. These funds, the agency alleges, were deliberately layered to conceal their illicit origin. Stay updated with the latest local news from your city on Times of India (TOI). Check upcoming bank holidays , public holidays , and current gold rates and silver prices in your area.
The Hindu
2 days ago
- The Hindu
ED charges Hyderabad firm in case of illegal Tramadol export to Pakistan
The Enforcement Directorate's (ED) Hyderabad Zonal Office has filed a prosecution complaint against Lucent Drugs Pvt. Ltd. and its key executives in connection with the illegal export of the psychotropic substance Tramadol — a synthetic opioid — to Pakistan, in violation of the NDPS Act. The Special PMLA Court in Hyderabad took cognisance of the case on August 6. The investigation began following a Narcotics Control Bureau (NCB) complaint alleging illegal exports, contravention of NDPS Act orders, and forgery of records linked to export authorisations. Those named in the complaint include the company's managing director Vinod Jain, associate vice-president Devarasetty Sai Vikas, logistics and sales executive Gangula Eswara Rao, and others. According to the ED, the Lucent Drugs had been manufacturing and exporting Tramadol to various overseas clients, including those in Pakistan. While the company initially obtained clearance from the Central Bureau of Narcotics for exports to Pakistan, later approvals were denied. 'To bypass the ban, the accused allegedly re-exported 13,800 kg of Tramadol worth about ₹4.12 crore to Pakistan through a Denmark-based company, CHR Olesen Pharmaceuticals, and 5,000 kg worth about ₹1.34 crore via Malaysia-based SM Biomed,' an officer from ED said. The ED said that the illegal shipments generated proceeds of crime totalling ₹5.46 crore, which were routed into the company's bank accounts and later mixed with legitimate business revenues to disguise their origin. Earlier, the agency had attached the company's immovable properties, including a building and factory premises, valued at ₹5.46 crore.
